Finance

Beta
Lists
HUBS:NYSE
HubSpot Inc
$185.47
+8.92%
(+15.19) 1D
$186.01
+0.29% (+0.54)
After hours
Closed: Jun 26, 4:00:12 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HUBS...
Open
$172.31
High
$185.59
Low
$172.31
Mkt. cap
9.50B
Avg. vol.
2.08M
Volume
2.84M
P/E ratio
100.07
52-wk high
$568.16
52-wk low
$169.63
EPS
$1.85
Beta
1.22
Shares outstanding
51.22M
No. of employees
9K
Open
$172.31
High
$185.59
Low
$172.31
Mkt. cap
9.50B
Avg. vol.
2.08M
Volume
2.84M
P/E ratio
100.07
52-wk high
$568.16
52-wk low
$169.63
EPS
$1.85
Beta
1.22
Shares outstanding
51.22M
No. of employees
9K
News stories
From sources across the web
Profile
HubSpot, Inc. is a US-based developer and marketer of software products for marketing, sales, and customer service. HubSpot was founded by Brian Halligan and Dharmesh Shah in 2006. The global headquarters is in Cambridge, Massachusetts. Wikipedia
About HubSpot Inc
CEOYamini Rangan
Employees9.02K
FoundedJun 2006
Headquarters-
SectorApplication software
Website-
Analyst ratings
Based on 27 analysts giving stock ratings to HUBS in the past 3 months
Buy
Buy
19
Hold
7
Sell
1
12-month forecast
Based on 27 Wall Street analysts offering 12 month price targets for HUBS in the last 3 months.
Highest
Current $185.47
$382.00 (+105.96%)
Average
$272.21 (+46.77%)
Lowest
$180.00 (-2.95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Arti Vula
J.P. Morgan
Buy
Initiated
-
-
06/01/2026
Mark Murphy
J.P. Morgan
Buy
Initiated
-
-
06/01/2026
Terry Tillman
Truist Financial
Buy
Maintained
-
-
05/12/2026
Andrew Degasperi
Exane BNP Paribas
Hold
Downgraded
$210.00
+13.2%
05/11/2026
Raimo Lenschow
Barclays
Buy
Reiterated
$270.00
+45.6%
05/11/2026
Steven Koenig
Macquarie
Hold
Downgraded
$190.00
+2.4%
05/10/2026
Kirk Materne
Evercore ISI
Hold
Maintained
$225.00
+21.3%
05/08/2026
Brian Peterson
Raymond James
Buy
Maintained
$250.00
+34.8%
05/08/2026
Siti Panigrahi
Mizuho Securities
Buy
Maintained
$260.00
+40.2%
05/08/2026
David Hynes
Canaccord Genuity
Buy
Reiterated
$335.00
+80.6%
05/08/2026
Kenneth Wong
Oppenheimer
Buy
Reiterated
$275.00
+48.3%
05/08/2026
J. Parker Lane
Stifel Nicolaus
Buy
Reiterated
$275.00
+48.3%
05/08/2026
Rishi Jaluria
RBC Capital
Buy
Reiterated
$350.00
+88.7%
05/07/2026
Tyler Radke
Citi
Hold
Downgraded
$230.00
+24%
05/08/2026
Gabriela Borges
Goldman Sachs
Buy
Maintained
$382.00
+106%
05/08/2026
Firoz Valliji
Bernstein
Buy
Maintained
$381.00
+105.4%
05/08/2026
Joshua Reilly
Needham
Buy
Maintained
$300.00
+61.8%
05/08/2026
Billy Fitzsimmons
Piper Sandler
Buy
Maintained
$250.00
+34.8%
05/08/2026
Elizabeth Porter
Morgan Stanley
Buy
Reiterated
$350.00
+88.7%
05/08/2026
Taylor McGinnis
UBS
Buy
Reiterated
$250.00
+34.8%
05/08/2026
Matt Bullock
Bank of America Securities
Sell
Downgraded
$180.00
-2.9%
05/08/2026
Jackson Ader
KeyBanc
Buy
Maintained
$290.00
+56.4%
05/08/2026
Matthew VanVliet
Cantor Fitzgerald
Hold
Downgraded
$200.00
+7.8%
05/07/2026
Arjun Bhatia
William Blair
Hold
Downgraded
-
-
05/09/2026
Derrick Wood
TD Cowen
Hold
Maintained
$250.00
+34.8%
05/08/2026
Samad Samana
Jefferies
Buy
Maintained
$250.00
+34.8%
05/07/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$275.00
+48.3%
05/08/2026
Keith Bachman
BMO Capital
Buy
Maintained
$230.00
+24%
05/05/2026
Ryan MacWilliams
Wells Fargo
Buy
Reiterated
$350.00
+88.7%
04/22/2026
Omar Sheikh
Rothschild & Co Redburn
Hold
Reiterated
$320.00
+72.5%
03/10/2026
Nick Altmann
BTIG
Buy
Maintained
$300.00
+61.8%
02/12/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$2.72 / $2.47
+10.24%beat
Revenue / Est. (USD)
881.00M / 863.34M
+2.05%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
760.87M
809.52M
846.75M
881.00M
Cost of goods sold
122.16M
133.52M
137.70M
145.69M
Cost of revenue
122.16M
133.52M
137.70M
145.69M
Research and development expenses
237.34M
227.71M
220.79M
234.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
423.97M
436.02M
440.10M
472.07M
Operating expense
661.31M
663.73M
660.89M
706.26M
Total operating expenses
783.48M
797.25M
798.59M
851.96M
Operating income
-22.61M
12.27M
48.16M
29.04M
Other non operating income
-660.00K
-
-
-
EBT including unusual items
-5.46M
23.14M
61.66M
39.29M
EBT excluding unusual items
-5.21M
26.13M
60.30M
40.55M
Income tax expense
-2.20M
6.60M
7.23M
6.74M
Effective tax rate
40.30%
28.53%
11.73%
17.15%
Other operating expenses
-
-
-
-
Net income
-3.26M
16.54M
54.43M
32.55M
Net profit margin
-0.43%
2.04%
6.43%
3.70%
Earnings per share
2.19
2.66
3.09
2.72
Interest and investment income
18.29M
14.25M
13.11M
12.88M
Interest expense
-227.00K
-4.00K
-
-245.00K
Net interest expenses
18.06M
14.25M
13.11M
12.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.72M
14.77M
57.62M
33.28M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of HUBS
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer